Top

Published in:

21-09-2023 | Constipation | CE - MEDICAL ILLUSTRATION

Chilaiditi’s syndrome: about a case of apparent pneumoperitoneum

Authors: Filipe Silva Vilela, Rita Pinto, Luís Dias, Vânia Gomes, Céu Rodrigues

Published in: Internal and Emergency Medicine | Issue 1/2024

Excerpt

A 66-year-old man presented to the internal medicine clinic for re-evaluation after pneumonia, reporting new complaints of abdominal pain and constipation with tenderness and defense upon palpation. …

Kumar A, Mehta D (2023) Chilaiditi syndrome [Internet]. StatPearls Publishing, Treasure Island. https://www.ncbi.nlm.nih.gov/books/NBK554565/ [cited 2 May 2023]

Moaven O, Hodin RA (2012) Chilaiditi syndrome: a rare entity with important differential diagnoses. Gastroenterol Hepatol [Internet] 8(4):276–278. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3380266/

Guerra F, Sacchetti R (2016) Chilaiditi syndrome. An uncommon cause of crampy, upper abdominal pain. Ann Hepatol [Internet] 15(5):773–774. https://www.elsevier.es/en-revista-annals-hepatology-16-articulo-chilaiditi-syndrome-an-uncommon-cause-S1665268119306416 [cited 2 May 2023]

Mandal S, Singh S, Ray B, Thakur R, Shah A, Kolade VO (2022) Air under the diaphragm—perforation or Chilaiditi sign? Baylor Univ Med Center Proc [Internet] 35(1):108–110. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8682840/ [cited 2 May 2023]

Title: Chilaiditi’s syndrome: about a case of apparent pneumoperitoneum
Authors: Filipe Silva Vilela
Rita Pinto
Luís Dias
Vânia Gomes
Céu Rodrigues
Publication date: 21-09-2023
Publisher: Springer International Publishing
Keywords: Constipation
Constipation
Published in: Internal and Emergency Medicine / Issue 1/2024
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI: https://doi.org/10.1007/s11739-023-03423-4

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2024

Intravenous paracetamol compared to non-steroidal anti-inflammatory drugs and opioids for acute pain in emergency departments

Quantitative research assessment: using metrics against gamed metrics

Correction: Value of hospital datasets of COVID-19 patients across different pandemic periods: challenges and opportunities

Antiphospholipid syndrome: are old school VKAs still the best choice?

A balloon is better than diet: the role of lifestyle changes in the management of obesity and steatotic liver, and need for a winning strategy

Association between non-dipping blood pressure pattern and different glucometabolic profile during oral glucose tolerance test

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials